Actuate Therapeutics, Inc.
Feinberg School of Medicine
Department of Pharmacology
Center for Developmental Therapeutics
Actuate Therapeutics, Inc. is a private biopharmaceutical company developing novel therapeutics that target Glycogen Synthase Kinase-3β (GSK-3β). Activity and overexpression of GSK-3β have been implicated in many conditions, including Alzheimer’s disease, bipolar disorder, diabetes mellitus type II, inflammatory conditions, and cancer.